nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Fenethylline—Pentoxifylline—systemic scleroderma	0.557	0.581	CrCrCtD
Methamphetamine—Lisdexamfetamine—Lisinopril—systemic scleroderma	0.146	0.153	CrCrCtD
Methamphetamine—Nateglinide—Lisinopril—systemic scleroderma	0.131	0.136	CrCrCtD
Methamphetamine—Aspartame—Lisinopril—systemic scleroderma	0.124	0.13	CrCrCtD
Methamphetamine—Digestion impaired—Leflunomide—systemic scleroderma	0.00185	0.0457	CcSEcCtD
Methamphetamine—Erectile dysfunction—Captopril—systemic scleroderma	0.000868	0.0214	CcSEcCtD
Methamphetamine—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.000838	0.0207	CcSEcCtD
Methamphetamine—Tremor—Pentoxifylline—systemic scleroderma	0.000812	0.02	CcSEcCtD
Methamphetamine—Agitation—Pentoxifylline—systemic scleroderma	0.000797	0.0197	CcSEcCtD
Methamphetamine—Palpitations—Pentoxifylline—systemic scleroderma	0.000766	0.0189	CcSEcCtD
Methamphetamine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00069	0.017	CcSEcCtD
Methamphetamine—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.000683	0.0168	CcSEcCtD
Methamphetamine—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.000661	0.0163	CcSEcCtD
Methamphetamine—Insomnia—Pentoxifylline—systemic scleroderma	0.00064	0.0158	CcSEcCtD
Methamphetamine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000623	0.0154	CcSEcCtD
Methamphetamine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.000615	0.0152	CcSEcCtD
Methamphetamine—Constipation—Pentoxifylline—systemic scleroderma	0.000605	0.0149	CcSEcCtD
Methamphetamine—Palpitations—Captopril—systemic scleroderma	0.000581	0.0143	CcSEcCtD
Methamphetamine—Urticaria—Pentoxifylline—systemic scleroderma	0.000562	0.0139	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisone—systemic scleroderma	0.000543	0.0134	CcSEcCtD
Methamphetamine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.000539	0.0133	CcSEcCtD
Methamphetamine—Dyspepsia—Mometasone—systemic scleroderma	0.000537	0.0133	CcSEcCtD
Methamphetamine—Tachycardia—Captopril—systemic scleroderma	0.000523	0.0129	CcSEcCtD
Methamphetamine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000521	0.0129	CcSEcCtD
Methamphetamine—Insomnia—Captopril—systemic scleroderma	0.000485	0.012	CcSEcCtD
Methamphetamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000484	0.0119	CcSEcCtD
Methamphetamine—Tremor—Mycophenolic acid—systemic scleroderma	0.000484	0.0119	CcSEcCtD
Methamphetamine—Palpitations—Leflunomide—systemic scleroderma	0.000478	0.0118	CcSEcCtD
Methamphetamine—Agitation—Mycophenolic acid—systemic scleroderma	0.000475	0.0117	CcSEcCtD
Methamphetamine—Dyspepsia—Captopril—systemic scleroderma	0.000472	0.0116	CcSEcCtD
Methamphetamine—Dizziness—Pentoxifylline—systemic scleroderma	0.000468	0.0115	CcSEcCtD
Methamphetamine—Constipation—Captopril—systemic scleroderma	0.000458	0.0113	CcSEcCtD
Methamphetamine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000456	0.0113	CcSEcCtD
Methamphetamine—Psychotic disorder—Prednisone—systemic scleroderma	0.000448	0.0111	CcSEcCtD
Methamphetamine—Headache—Pentoxifylline—systemic scleroderma	0.000443	0.0109	CcSEcCtD
Methamphetamine—Tremor—Lisinopril—systemic scleroderma	0.000436	0.0108	CcSEcCtD
Methamphetamine—Tachycardia—Leflunomide—systemic scleroderma	0.000431	0.0106	CcSEcCtD
Methamphetamine—Diarrhoea—Mometasone—systemic scleroderma	0.000418	0.0103	CcSEcCtD
Methamphetamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000411	0.0102	CcSEcCtD
Methamphetamine—Palpitations—Lisinopril—systemic scleroderma	0.000411	0.0101	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000404	0.00997	CcSEcCtD
Methamphetamine—Insomnia—Leflunomide—systemic scleroderma	0.0004	0.00986	CcSEcCtD
Methamphetamine—Dyspepsia—Leflunomide—systemic scleroderma	0.000389	0.0096	CcSEcCtD
Methamphetamine—Headache—Mometasone—systemic scleroderma	0.000382	0.00944	CcSEcCtD
Methamphetamine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00943	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000381	0.00941	CcSEcCtD
Methamphetamine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000381	0.00941	CcSEcCtD
Methamphetamine—Constipation—Leflunomide—systemic scleroderma	0.000378	0.00933	CcSEcCtD
Methamphetamine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00924	CcSEcCtD
Methamphetamine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000371	0.00916	CcSEcCtD
Methamphetamine—Tachycardia—Lisinopril—systemic scleroderma	0.000371	0.00915	CcSEcCtD
Methamphetamine—Diarrhoea—Captopril—systemic scleroderma	0.000367	0.00905	CcSEcCtD
Methamphetamine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000365	0.00901	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000364	0.00898	CcSEcCtD
Methamphetamine—Constipation—Mycophenolic acid—systemic scleroderma	0.00036	0.0089	CcSEcCtD
Methamphetamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00889	CcSEcCtD
Methamphetamine—Dizziness—Captopril—systemic scleroderma	0.000355	0.00875	CcSEcCtD
Methamphetamine—Urticaria—Leflunomide—systemic scleroderma	0.000351	0.00866	CcSEcCtD
Methamphetamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000345	0.00851	CcSEcCtD
Methamphetamine—Insomnia—Lisinopril—systemic scleroderma	0.000343	0.00848	CcSEcCtD
Methamphetamine—Headache—Captopril—systemic scleroderma	0.000336	0.00829	CcSEcCtD
Methamphetamine—Dyspepsia—Lisinopril—systemic scleroderma	0.000334	0.00825	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000328	0.00809	CcSEcCtD
Methamphetamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000326	0.00803	CcSEcCtD
Methamphetamine—Constipation—Lisinopril—systemic scleroderma	0.000325	0.00801	CcSEcCtD
Methamphetamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00801	CcSEcCtD
Methamphetamine—Diarrhoea—Azathioprine—systemic scleroderma	0.00032	0.0079	CcSEcCtD
Methamphetamine—Dizziness—Azathioprine—systemic scleroderma	0.000309	0.00764	CcSEcCtD
Methamphetamine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000305	0.00753	CcSEcCtD
Methamphetamine—Diarrhoea—Leflunomide—systemic scleroderma	0.000302	0.00746	CcSEcCtD
Methamphetamine—Urticaria—Lisinopril—systemic scleroderma	0.000302	0.00744	CcSEcCtD
Methamphetamine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00743	CcSEcCtD
Methamphetamine—Headache—Azathioprine—systemic scleroderma	0.000293	0.00723	CcSEcCtD
Methamphetamine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00723	CcSEcCtD
Methamphetamine—Dizziness—Leflunomide—systemic scleroderma	0.000292	0.00721	CcSEcCtD
Methamphetamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000288	0.00712	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00709	CcSEcCtD
Methamphetamine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00702	CcSEcCtD
Methamphetamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00028	0.0069	CcSEcCtD
Methamphetamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000279	0.00688	CcSEcCtD
Methamphetamine—Headache—Leflunomide—systemic scleroderma	0.000277	0.00683	CcSEcCtD
Methamphetamine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00652	CcSEcCtD
Methamphetamine—Headache—Mycophenolic acid—systemic scleroderma	0.000264	0.00652	CcSEcCtD
Methamphetamine—Diarrhoea—Lisinopril—systemic scleroderma	0.00026	0.00641	CcSEcCtD
Methamphetamine—Agitation—Prednisone—systemic scleroderma	0.000254	0.00627	CcSEcCtD
Methamphetamine—Dizziness—Lisinopril—systemic scleroderma	0.000251	0.0062	CcSEcCtD
Methamphetamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00605	CcSEcCtD
Methamphetamine—Headache—Lisinopril—systemic scleroderma	0.000238	0.00587	CcSEcCtD
Methamphetamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00562	CcSEcCtD
Methamphetamine—Tachycardia—Prednisone—systemic scleroderma	0.00022	0.00543	CcSEcCtD
Methamphetamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00543	CcSEcCtD
Methamphetamine—TAAR1—lung—systemic scleroderma	0.000213	0.123	CbGeAlD
Methamphetamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00514	CcSEcCtD
Methamphetamine—Insomnia—Prednisone—systemic scleroderma	0.000204	0.00503	CcSEcCtD
Methamphetamine—Dyspepsia—Prednisone—systemic scleroderma	0.000198	0.0049	CcSEcCtD
Methamphetamine—Constipation—Prednisone—systemic scleroderma	0.000193	0.00476	CcSEcCtD
Methamphetamine—Urticaria—Prednisone—systemic scleroderma	0.000179	0.00442	CcSEcCtD
Methamphetamine—Insomnia—Methotrexate—systemic scleroderma	0.00017	0.00421	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000166	0.0041	CcSEcCtD
Methamphetamine—Dyspepsia—Methotrexate—systemic scleroderma	0.000166	0.00409	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000163	0.00402	CcSEcCtD
Methamphetamine—Diarrhoea—Prednisone—systemic scleroderma	0.000154	0.00381	CcSEcCtD
Methamphetamine—Urticaria—Methotrexate—systemic scleroderma	0.00015	0.00369	CcSEcCtD
Methamphetamine—Dizziness—Prednisone—systemic scleroderma	0.000149	0.00368	CcSEcCtD
Methamphetamine—Headache—Prednisone—systemic scleroderma	0.000141	0.00349	CcSEcCtD
Methamphetamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000139	0.00343	CcSEcCtD
Methamphetamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000129	0.00318	CcSEcCtD
Methamphetamine—Dizziness—Methotrexate—systemic scleroderma	0.000125	0.00308	CcSEcCtD
Methamphetamine—Headache—Methotrexate—systemic scleroderma	0.000118	0.00291	CcSEcCtD
Methamphetamine—SLC18A2—digestive system—systemic scleroderma	8.68e-05	0.05	CbGeAlD
Methamphetamine—SLC22A3—connective tissue—systemic scleroderma	8.56e-05	0.0493	CbGeAlD
Methamphetamine—SLC18A2—tendon—systemic scleroderma	8.26e-05	0.0476	CbGeAlD
Methamphetamine—MAOB—connective tissue—systemic scleroderma	7.92e-05	0.0456	CbGeAlD
Methamphetamine—SLC22A3—smooth muscle tissue—systemic scleroderma	7.83e-05	0.0451	CbGeAlD
Methamphetamine—SLC18A2—lung—systemic scleroderma	7.25e-05	0.0418	CbGeAlD
Methamphetamine—MAOA—connective tissue—systemic scleroderma	6.76e-05	0.0389	CbGeAlD
Methamphetamine—SLC6A4—digestive system—systemic scleroderma	6.02e-05	0.0347	CbGeAlD
Methamphetamine—MAOB—digestive system—systemic scleroderma	5.72e-05	0.033	CbGeAlD
Methamphetamine—SLC22A5—skin of body—systemic scleroderma	5.62e-05	0.0324	CbGeAlD
Methamphetamine—SLC6A3—lung—systemic scleroderma	5.48e-05	0.0316	CbGeAlD
Methamphetamine—MAOB—tendon—systemic scleroderma	5.44e-05	0.0314	CbGeAlD
Methamphetamine—ADRA2A—connective tissue—systemic scleroderma	5.18e-05	0.0299	CbGeAlD
Methamphetamine—SLC22A3—lung—systemic scleroderma	5.16e-05	0.0297	CbGeAlD
Methamphetamine—SLC6A4—lung—systemic scleroderma	5.03e-05	0.0289	CbGeAlD
Methamphetamine—MAOA—digestive system—systemic scleroderma	4.88e-05	0.0281	CbGeAlD
Methamphetamine—MAOB—lung—systemic scleroderma	4.78e-05	0.0275	CbGeAlD
Methamphetamine—MAOA—tendon—systemic scleroderma	4.65e-05	0.0268	CbGeAlD
Methamphetamine—SLC22A5—digestive system—systemic scleroderma	4.5e-05	0.0259	CbGeAlD
Methamphetamine—ADRA2C—tendon—systemic scleroderma	4.47e-05	0.0257	CbGeAlD
Methamphetamine—SLC6A2—lung—systemic scleroderma	4.42e-05	0.0255	CbGeAlD
Methamphetamine—SLC22A5—tendon—systemic scleroderma	4.28e-05	0.0246	CbGeAlD
Methamphetamine—MAOA—lung—systemic scleroderma	4.08e-05	0.0235	CbGeAlD
Methamphetamine—ADRA2C—lung—systemic scleroderma	3.92e-05	0.0226	CbGeAlD
Methamphetamine—SLC22A5—lung—systemic scleroderma	3.75e-05	0.0216	CbGeAlD
Methamphetamine—ADRA2A—tendon—systemic scleroderma	3.56e-05	0.0205	CbGeAlD
Methamphetamine—ADRA2A—lung—systemic scleroderma	3.13e-05	0.018	CbGeAlD
Methamphetamine—CYP2D6—digestive system—systemic scleroderma	2.9e-05	0.0167	CbGeAlD
